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In addition to the canonical B-form structure ﬁrst described by Watson and Crick, DNA can adopt a number of alternative
structures. These non-B-form DNA secondary structures form spontaneously on tracts of repeat sequences that are abundant in
genomes. In addition, structured forms of DNA with intrastrand pairing may arise on single-stranded DNA produced transiently
during various cellular processes. Such secondary structures have a range of biological functions but also induce genetic instability.
Increasing evidence suggests that genomic instabilities induced by non-B DNA secondary structures result in predisposition
to diseases. Secondary DNA structures also represent a new class of molecular targets for DNA-interactive compounds that
might be useful for targeting telomeres and transcriptional control. The equilibrium between the duplex DNA and formation
of multistranded non-B-form structures is partly dependent upon the helicases that unwind (resolve) these alternate DNA
structures. With special focus on tetraplex, triplex, and cruciform, this paper summarizes the incidence of non-B DNA structures
and their association with genomic instability and emphasizes the roles of RecQ-like DNA helicases in genome maintenance by
resolution of DNA secondary structures. In future, RecQ helicases are anticipated to be additional molecular targets for cancer
chemotherapeutics.
1.Introduction
Structure of the right-handed B-form DNA has been known
since 1953 [1]. Instead of being a conformationally homoge-
nous molecule, DNA has the capability of adopting several
types of conformations as dictated by its sequence [2]. As
early as 1957, association of ribonucleic poly-A and poly-U
polymers into three-stranded complexes was revealed using
sedimentation coeﬃcient and optical absorption measure-
ments [3]. It was later shown by atomic resolution single-
crystal X-ray diﬀraction analysis that the DNA hexamer
d(CpGpCpGpCpG) forms a left-handed conformation (Z-
DNA) with altered helical parameters relative to the right-
handed B-form [4]. This was followed by the identiﬁcation
of cruciform structures formed by inverted repeats [5, 6].
Finally, guanine-rich motifs in DNA were discovered to
form parallel four-stranded complexes called tetraplex, G-
quadruplex, or G4 DNA [7]. More than ten diﬀerent DNA
conformations have now been discovered [8], and these are
often referred to as secondary structures, alternative DNA,
or non-B DNA. A non-B database has been developed for
prediction of alternative DNA structures including Z-DNA
motifs, quadruplex-forming motifs, inverted repeats, mirror
repeats and direct repeats, and their associated subsets of
cruciforms, triplex, and slipped structures, respectively [9].
Non-B DNA structures are functional genomic elements
that play a variety of roles in the cell [10]. These include
gene function and regulation [11], immune response [12],
telomere maintenance [13], recombination [14], antigenic
variation in human pathogens [15], and the generation of
genomic diversity [16]. The DNA secondary structures are
suggested to be involved in regulation at both transcriptional
and translational levels; however, when the subtle balance
between the replication, transcriptional, and repair machin-
ery is impaired, these secondary structures may induce
geneticinstability.Alternatestructure-formingsequencesare
known to be unstable and represent hotspots for deletion
or recombination in bacteria, yeast, and mammals [17–20].
This genetic instability has generally been related to DNA
replication because non-B structures cause DNA polymerase2 Journal of Nucleic Acids
pausing in vitro and replication fork pausing in vivo [21].
Slow replication was observed in an inverted repeat sequence
in Escherichia coli [22], and inverted repeats lead to deletions
or chromosomal rearrangements more frequently in yeast
that are deﬁcient in DNA polymerase activity [23, 24]. Slow
progression of the replication fork could facilitate formation
of secondary structures at long tracts of single-stranded
DNA in the lagging-strand template [25]. These secondary
structures pose obstacle to replication fork progression
causing fork arrest and/or collapse ultimately leading to
double-strand breaks (DSBs) and genome rearrangements
[26, 27]. The formation of alternative DNA structures can
also activate nucleotide excision and SOS pathways resulting
in segments of single-stranded DNA (ssDNA) [28]. Such
ssDNA regions can be converted to DSBs during replica-
tion and lead to mutations through mechanisms such as
homologous recombination or nonhomologous end joining
[29]. Conditions that favor the structural transitions from
B-DNA to non-B DNA lead to genetic instability in model
systems [27]. Alternative structure-mediated mutagenesis
has been implicated in the incidence of gross rearrangements
and deletions as well as point mutations [30–32]. There
is signiﬁcant circumstantial evidence for the involvement
of DNA secondary structures in association with genetic
instability leading to human disease [33, 34].
The vastness of mutagenic capability would be predicted
to reduce the prevalence of secondary structure-forming
tracts in genomes; however they are abundant and often
enriched in the regulatory regions of genes [9]. With such an
array of challenging sequence elements, it is evident that cells
have developed the capacity for controlling the potential of
these sequences for genome destabilization. Among several
elucidatedmechanismstoresolvesecondaryDNAstructures,
RecQ helicases represent an important class of enzymatic
activities that are utilized to counteract such challenge to
genomic stability.
2.RecQ Helicases
TheRecQfamilyrepresentsoneofthemosthighlyconserved
groupsofDNAhelicases[35–39].Bacteriaandbuddingyeast
have one RecQ homolog, RecQ and SGS1, respectively. The
RecQ helicase family has 5 homologs in the human genome:
RECQ1, WRN, BLM, RecQ4, and RecQ5β (Figure 1). RecQ
helicases share a centrally located helicase domain that
couples nucleotide hydrolysis to DNA unwinding and
deﬁnes the RecQ family. Many, but not all, RecQ helicases
contain additional conserved RQC (RecQ C-terminal) and
HRDC (helicase and RNaseD C-terminal) domains, which
are implicated in protein interactions [40, 41] and DNA
binding [42]. Eukaryotic RecQ helicases have, in addition,
further N- and C-terminal extensions that are involved in
protein-protein interactions and postulated to lend unique
functional characteristics to each helicase [43, 44]. Certain
RecQ homologues also have strongly acidic regions that have
been shown to mediate interaction with single-strand DNA-
binding proteins such as RPA [37]. Furthermore, nuclear
localizationsignal(NLS)hasbeenidentiﬁedforseveralRecQ
proteins (Figure 1)[ 37].
RecQ helicases unwind DNA duplex with 3 -5  polarity
in a reaction that is dependent of NTP hydrolysis [37].
Curiously, several RecQ proteins have been demonstrated to
also have the ability to promote annealing of complementary
strands in a reaction that is inhibited by the presence of
ATP [37]. It was conﬁrmed that ATP binding to the protein
modulates oligomeric state of RECQ1 and regulates these
apparently conﬂicting biochemical activities [45, 46].
RecQ helicases are remarkable among all DNA helicases
for two primary reasons. First, in addition to unwinding
duplexDNA,theyarecapableofunwindingavarietyofDNA
substrates containing noncanonical structures including
forkedduplexes,displacementloops(D-loops;anintermedi-
ate in homologous recombination reactions), triple helices,
3- or 4-way junctions, and G-quadruplex DNA [37, 47].
In fact, in many instances, they prefer these substrates
to standard duplex DNA. Second, germline mutations in
three human RecQ helicase homologs WRN, BLM, and
RECQ4, which are located on chromosomes 8p-12, 15q-
26.1, and 8q-24.3, respectively, give rise to rare genetic
disorders of Werner, Bloom, and Rothmund-Thomson/
RAPADILINO/Baller-Gerold syndromes, respectively, all of
which are characterized by chromosomal instability and
predisposition to cancer [48–51]. Distinct clinical features of
thesedisordersindicatethathumanRecQhomologsperform
unique cellular functions. Cellular studies point to critical
requirement of RECQ1 and RecQ5β [52, 53], but defects
in these have not been associated with a human disease
yet. As reviewed in next sections, collective biochemical,
cellular, and genetic ﬁndings signify a pivotal role of RecQ
helicases in resolution of non-B DNA structures and genome
maintenance.
3. Prevalence, Consequences, and Unravelingof
Non-B Secondary DNA Structures
Genomic maintenance entails highly regulated interaction of
intrinsic factors such as the nature of sequence or the action
of DNA replication and repair proteins and extrinsic factors
such as environmental mutagens. Repetitive sequences in the
genomes have the propensity to form complex secondary
structures which could lead to diverse types of genomic
instability. One of the common mechanisms of alternative
structure-induced instability is obstruction of replication
fork progression leading to fork stalling and/or collapse
[54]. RecQ helicases are proposed as genome caretakers
and guardians of DNA replication forks [55]. The following
sections summarize impact of certain speciﬁc non-B DNA
structures on genomic stability and review the roles of RecQ
helicases in resolving these structures.
3.1. Cruciforms
3.1.1. Cruciform DNA Structures and Their Occurrence in
Genomes. A cruciform structure is formed by intrastrand
basepairingofinvertedrepeatsequencesandischaracterizedJournal of Nucleic Acids 3
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Figure 1: The RecQ helicase family. Proteins are aligned by their conserved helicase domain. Conserved domains and motifs in each group
are shown by diﬀerent colors as depicted at the bottom.
by the presence of a four-way junction in which two
of the branches are hairpin structures formed on each
strand of the inverted repeat [5]( Figure 2(a)). The bases
located between the inverted repeats do not self-pair and
instead form the apical loops of the hairpins; however the
overall structure is stabilized by the free energy of negative
supercoiling [56]. Cruciform is structurally similar to a
Holliday Junction (HJ) recombination intermediate [57].
In fact, cruciform structures formed by extrusion of an
inverted repeat sequence in supercoiled plasmids have been
extensively used to study the mechanistic properties of HJ-
resolving enzymes [58, 59].
The existence of cruciforms has been demonstrated
in vitro [60]a n din vivo [61–63]. Cruciform structures
have been reported in the genome of E. coli [64]a s
well as mammalian cells [63]. Cruciform-forming inverted
repeat sequences have been found at the operator and
transcription termination regions [65], as well as at the
replication origin region [63, 66]. The distribution of such
sequences often overlaps with chromosomal regions prone
t og r o s sr e a r r a n g e m e n t s[ 67]. Because cruciform structures
are energetically unfavorable, they are thought to form
transiently in vivo as stable structures. The action of cellular
factors such as junction speciﬁc nucleases, binding proteins,
and DNA helicases is suggested to aﬀect the equilibrium and
the rate of formation of cruciform structures in vivo [68].
3.1.2. Cruciforms and Genomic Instability. Palindromes, a
speciﬁc type of inverted repeat separated by only very few
base pairs, are poorly tolerated in E. coli cells and are
underrepresented in the S. cerevisiae and human genomes
[69, 70] presumably due to their tendency to form hairpin
and cruciform structures, which could be recognized and
cleaved by a nuclease [71] or could aﬀect or slow down
DNA replication [72]. Cruciform structures are found in
mutagenic hotspots, and their presence has been suggested
to be etiologic in causing rearrangements and chromosomal
instability in humans [2, 73, 74]. The AT-rich palindromic
repeats involved in the recurrent t(11;22) constitutional
translocation favor adopting a cruciform structure in vitro
and involve frequent DSBs [75, 76]. Direct Alu repeats artiﬁ-
cially inserted in an inverted orientation in the yeast genome
undergo DSBs and enter a break-fusion cycle resulting in
dicentric chromosomes [77]. It has been proposed that the
break might be caused by a cruciform-speciﬁc resolution
activity similar to HJ resolvase, which generally is thought to
act on intermediates produced through homologous recom-
bination in the repair of DSBs or stalled replication [67].
However, recent studies show that nearby inverted repeats
in budding and ﬁssion yeasts recombine spontaneously and
frequently to form dicentric and acentric chromosomes
independent of DSB formation, possibly by a replication
mechanism involving template switching [78, 79].
3.1.3. Cruciform Resolvases. Four-way DNA joint molecules,
termed HJs, are key intermediates in recombination [80].
Proteins with the enzymatic ability to cleave synthetic HJs
in vitro have been termed HJ “resolvases,” and these DNA
junction-resolving enzymes exhibit considerable selectivity
for the structure of their substrates [81]. Ec o l iRuvC and its
associated proteins RuvA and RuvB constitute the archetypal
resolvase system [82]. RuvC is a dimeric protein that pro-
motes HJ resolution by introducing a pair of symmetrically
related nicks in two diametrically opposed strands across
the junction point [82]. Ongoing search for the eukaryotic
equivalent of bacterial RuvC HJ resolvase has led to the
discovery of a number of DNA endonucleases, including
Mus81-Mms4/EME1 [83], Slx-Slx4/BTBD12/MUS312 [84–
86], XPF-ERCC1 [87], and Yen1/GEN1 [88, 89]. Further-
more, MUS81-EME1 also forms part of a larger nuclease
complex containing SLX1-SLX4 and XPF-ERCC1 raising the
possibility that these nucleases cooperate to process HJs
[81]. Thus, it appears that eukaryotes possess alternative,
and mechanistically varied, ways to process HJs, perhaps
reﬂecting the critical importance of this step for cell viability
and mutation avoidance.4 Journal of Nucleic Acids
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Figure 2: Schematic representation of certain non-B-form DNA structures. DNA can assume various alternate conformations depending
upon the sequences. (a) Cruciform structures are formed at inverted repeats and also as intermediates of homologous recombination
pathway, (b) Intermolecular triplex are formed by a triplex forming oligonucleotide (TFO, shown in blue) which binds to the purine-rich
strand of the target duplex through the major groove. (c) Intramolecular triplex DNA structures can form at homopurine·homopyrimidine
sequences with mirror symmetry, where a single-stranded region can bind in the major groove of the underlying DNA duplex to form a
three-stranded helix. (d) G4 DNA is formed via parallel arrangement of four G-rich DNA strands; green boxes represent four guanine bases
in planar arrangement via Hoogsteen base pairing. (e) Intermolecular G4 conformation is formed by DNA sequences with G-rich repeats
forming hairpins that dimerize to stabilize bimolecular structure. (f) Intramolecular G4 DNA (or fold-over G quadruplex) is formed by
single DNA strand with either four G-rich repeats or longer G tract that can fold upon themselves to form the G4 structure.
3.1.4. Metabolism of Cruciform-Like Structures by RecQ Heli-
cases. Cellular and biochemical studies have established that
RecQ helicases are vital in the metabolism of cruciform-
like structures [90]. Loss of SGS1 in S. cerevisiae results in
the accumulation of HR-dependent replication intermedi-
ates that resemble HJs [91]. In humans, DNA processing
defects during replication and/or recombination have been
suggested to contribute to the molecular pathology of
Werner and Bloom syndromes [92]. Werner syndrome cells
fail to resolve recombination intermediates [93], and the
expression of wild-type WRN protein or RusA, a bacterial
enzyme that cleaves four-way junctions, was both shown
to rescue the WRN recombination defect and to improve
cell survival following DNA damage [94]. Cytogenetic
phenotype of elevated sister chromatid exchanges (SCEs) in
Bloom syndrome cells has suggested hyperrecombination or
aberrant resolution of DNA recombination intermediates in
theabsenceofactiveBLMprotein[95].Thus,apotentialrole
forbothWRNandBLMwouldbetopreventDNAstructures
including HJ that arise at blocked or collapsed replication
forks from being processed into mature recombinants [55].
Indeed, RecQ helicases preferentially resolve 4-way HJs
which are formally analogous to cruciform structures [37].
Several RecQ helicase proteins, including human BLM,
WRN, RECQ5, and RECQ1, and the yeast homolog SGS1
were shown to selectively bind HJ structures and to promote
ATP-dependent branch migration in vitro [44, 45, 96–99].
Furthermore, BLM [97], WRN [96], RECQ5 [44], and
RECQ1 [100] are capable of branch-migrating HJs over sev-
eral kilobases which is remarkable given that these helicases
normally display poor processivity in the absence of RPA
[37].ThebacterialHJcorerecognitionproteinRuvAinhibitsJournal of Nucleic Acids 5
HJ branch migration by BLM, WRN, RECQ1 or RECQ5β
suggestingthattheseRecQhelicasesspeciﬁcallyrecognizethe
HJ core where they initiate unwinding [37]. It is conceivable
that RecQ helicases may promote branch migration with a
mechanism similar to the oligomeric RuvAB branch migra-
tion motor wherein two RuvA tetramers bind the junction
and promote the loading of two RuvB hexamers on the two
arms of the junction [101]. This notion is supported by the
factthatBLM,WRN,andRECQ1formoligomericstructures
in solution [102]. The WRN protein binds HJ as an oligomer
[103], and an N-terminal fragment of BLM is known to
form hexamers and dodecamers [104]. Remarkably, the N-
terminal region (residues 1–56) of RECQ1 was found to be
essential for both oligomerization and HJ resolution activity
[105].
Slipped strand hairpins or cruciforms with single-
stranded regions are also formed at tracts of trinucleotide
repeats during replication and stall replication forks [10].
A structure-speciﬁc nuclease, Flap endonuclease 1 (FEN-1),
has been implicated in resolution of such structures [54, 106,
107].ThenucleaseactivityofFEN-1isrobustlystimulatedby
physical interaction with WRN [108, 109]. WRN and FEN-
1 directly interact at the sites of arrested replication forks
suggesting that the formation of a functional FEN-1/WRN
complex is important for resolving stalled DNA replication
forks[110].CleavageofanHJintermediateofforkregression
by FEN-1 requires WRN branch fork migration [110]; WRN
helicase activity initiating from the HJ core provides a suit-
able DNA molecule with a free 5  ssDNA end on which FEN-
1canloadtoultimatelycatalyzestructure-speciﬁccleavageof
the unwound 5  ssDNA arm [111]. However, stimulation of
FEN-1 is mediated by direct protein-protein interaction but
does not require WRN catalytic activity [108, 112]. In fact,
expressionofaconservednoncatalyticC-terminaldomainof
WRNnecessaryandsuﬃcientforthephysicalandfunctional
interaction with FEN-1 is suﬃcient to rescue the yeast dna2-
1 mutant phenotypes [113]. The conserved C-terminal in
BLM was subsequently also found to mediate a physical and
functionalinteractionwithFEN-1[109],andthephenotypes
of yeast dna2 mutants can be rescued by expression of
BLM [114]. Importantly, BLM stimulated FEN-1 cleavage
of foldback ﬂaps, bubbles, or triplet repeats in a helicase-
dependent manner [115, 116]. Thus, WRN and BLM
helicases likely act as very eﬀective remover of structures that
inhibit FEN-1 and thereby prevent duplications, expansions,
and other genome disruption [111].
Cruciform metabolism is also among critical functions
of certain RecQ family helicases that are mediated by the
species-speciﬁc interaction with topoisomerase III homologs
[90]; the Rmi1 protein serves as an additional component
of the heterotrimeric functional complex [117]. The major
role of the concerted helicase-topoisomerase complex is to
catenate or decatenate dsDNA, resulting in the resolution
or “dissolution” of double HJs [118, 119]. Double HJs
are shown to exist in vivo and are thought to arise when
both ends of a DSB invade a homologous sequence at
the ﬁnal steps of homologous recombination [120, 121].
Human and Drosophila BLM proteins, but not other RecQ
helicases, together with topoisomerase IIIα, have the ability
to catalyze double HJ dissolution on model DNA substrates
inareactionthatrequiresBLM-mediatedATPhydrolysisand
the active-site tyrosine residue of topoisomerase IIIα [118,
122]. BLAP75/RMI promotes BLM-dependent dissolution
reaction by recruiting topoisomerase IIIα to the double HJ
[123, 124]. Notably, this functional interaction is highly
speciﬁc, as the BLAP-75 topoisomerase IlIa pair has no
eﬀect on either WRN or E. coli RecQ helicase activity, and
E. coli Top3 cannot substitute for topoisomerase IlIα in the
enhancement of the BLM helicase activity [125]. Dissolution
of dHJs in S. cerevisiae is performed by the SGS1-Top3-
Rmi1 complex [126]. Recent data are consistent with SGS1
and Top3 acting together in vivo because cells lacking SGS1
or Top3 exhibited persistent HJ-containing DNA structures
following exposure to DNA damage [127].
Collectively, RecQ helicases constitute a remarkable
group of enzymes that promote resolution of HJs via non-
resolvase mechanisms, and this is believed to be one of their
critical functions in genome maintenance.
3.2. Triplex
3.2.1. Triplex Structures and Their Occurrence in Genomes.
Naturally occurring homopurine/homopyrimidine sequen-
ces can fold into triplex conﬁguration by binding a third
strand of DNA or RNA in the major groove of Watson-Crick
duplex DNA through Hoogsteen or reversed Hoogsteen
hydrogenbonds[128](Figure 2(c)).Intermoleculartriplexes
are formed when the triplex-forming strand originates
from a second DNA molecule, for example, triplex-forming
oligonucleotides (TFOs) [128]( Figure 2(b)). Intramolecular
triplexes are the major elements of H-DNAs in which the
third strand is provided by one of the strands of the same
duplex DNA molecule at homopurine:homopyrimidine
sequenceswithmirrorsymmetry[129].Unfavourablecharge
repulsion between the three negatively charged DNA strands
contributes to the low stability of triplexes under physio-
logical conditions. At physiological pH, triplex formation
usually involves a purine-rich third strand that is antiparallel
to the complementary strand and is stabilized by negative
supercoiling, modiﬁcation with phosphorothioate groups,
or polyvalent cations such as Mg2+ or polyamines such as
spermine and spermidine [129].
Triplexes have been shown to exist in chromosomes and
nuclei, and the existence of H-DNA structures has been
evidenced both in vitro and in vivo [130]. Triplex formation
in vivo is supported by the identiﬁcation of mammalian
proteins that bind speciﬁcally to them [131, 132]a n dt o
the polypyrimidine [133] and polypurine single strands
[18]. H-DNA conformations have been identiﬁed in vivo
by using triplex-speciﬁc monoclonal antibodies [134, 135]
and ﬂuorescent “in situ nondenaturing” hybridization [136].
The presence of an H-DNA conformation in vitro has
been demonstrated in constructs containing the sequences
of interest from E. coli and mammalian genomic DNA
or by using chemicals that modify nucleotides speciﬁcally
in single-stranded DNA or double-stranded DNA [137,
138]. The sequence-speciﬁc DNA recognition and binding6 Journal of Nucleic Acids
characteristics of synthetic TFOs have been extensively
studied because of their potential applications in genome
modiﬁcation and therapy [139]. Most annotated genes in
both the mouse and human genomes are predicted to
contain at least one unique potential TFO binding site [140].
Similarly, naturally occurring sequences capable of adopting
H-DNA structures are very abundant in mammalian cells
(∼1 in every 50,000bp in humans) [129, 141]. Majority of
polypurine·polypyrimidine sequences are located in introns,
promotersand5  or 3  untranslatedregionsandareenriched
in genes involved in cell signaling and cell communication
[142].Importantly,H-DNAstructure-formingsequencesare
found ﬂanking protooncogenes [143, 144].
3.2.2. Triplex and Genomic Instability. Naturally occurring
triplexes are sources of genomic instability, and TFO can
induce targeted mutagenesis, recombination, or DNA repair,
and can inhibit proliferation and induce apoptosis in
cultured cells [14, 31]. Genomic instability of human DNA
sequences that can form triplexes is associated with the
etiology of several diseases including neurological disorders
[34]. For example, the triplex-forming potential of a (GAA)n
repeat has been correlated with the genomic instability
and reduced frataxin gene expression in Friedreich’s ataxia,
a triplet repeat disorder [145]. The repeated sequence
was shown to inhibit DNA polymerization in vitro and
progression of replication forks in vivo suggesting that
the triplex formation by the Friedreich’s ataxia (GAA)n
repeat inhibits DNA replication [146, 147]. In addition
to posing block to replication progression [148], naturally
occurring triplex-forming sequences have been shown to
interfere with transcription [144]. Many breakpoints on
the translocated c-myc gene in Burkitt’s lymphoma and
t(12;15) BALB/c plasmacytomas are clustered around the
H-DNA-forming sequences in the promoter regions [149].
Indeed, the naturally occurring H-DNA structure-forming
sequence from the human c-MYC gene was shown to induce
DSBs within these sequences in mammalian cells [32]a n d
cause genomic instability in mice [149]. Collectively, these
studies imply that the triplex structures result in fragile
sites or mutation hotspots causing DSBs and subsequent
translocation of the gene [129]. As part of the mechanisms
wherebycellspreventthedeleteriouseﬀectsofalternateDNA
structures, triplex formation in vivo is likely to be at least
partly inhibited by destabilizing proteins or helicases.
3.2.3. Triplex Unwinding by RecQ Helicases. Triplex-forming
sequences have been demonstrated to block replication
in vitro [148]. Puriﬁed recombinant E. coli RecQ protein
partially alleviates triplex formation and facilitates fork
progression through triplex-forming DNA in vitro;l o s so f
RecQ signiﬁcantly increases the mutations caused by triplex-
forming DNA in vivo [150]. RecQ-deﬁcient E. coli utilize
RecG helicase for fork regression upon encountering triplex
structures and thereby restart replication [150]. A RecG
equivalent in human is not identiﬁed yet, but human BLM
and WRN helicases can unwind a DNA triple helix [151]a n d
also catalyze fork regression [152]. In vitro studies with triple
helices formed by a pyrimidine motif third strand demon-
strated that WRN and BLM catalyze triplex unwinding in
nucleoside triphosphate hydrolysis-dependent reaction and
require a free 3 -ssDNA overhang attached to the third
strand [151]. Triplex unwinding by BLM and WRN does not
require a single strand:double strand fork at the junction
of the third strand and the triplex [151] indicating that the
unwinding is promoted by inherent structural elements of
the triplex substrate; this might also be facilitated by the
oligomeric structures of these helicases [102]. More recently
it was demonstrated that DHX9 (nuclear DNA helicase II
(NDHII)orRNAhelicaseA(RHA))protein,asuperfamily2
helicase, preferentially unwinds intermolecular triplex DNA
substrates in vitro with a speciﬁc 3 -5  polarity with respect
to the displaced third strand (similar to BLM and WRN
helicase); this activity required a 3 -ssDNA overhang on the
third strand and was dependent on ATP hydrolysis [153].
In contrast, a 5 -ssDNA overhang on the triplex-forming
oligonucleotide is required to unwind the third strand of
the triplex structure by FANCJ, a superfamily 2 helicase that
unwinds DNA in the 5 -3  direction [154]. This is consistent
with the observations that FANCJ requires a preexisting
5 -ssDNA to unwind conventional B-form duplex DNA
substrates [155] and G-quadruplex DNA substrates [156].
Triplex unwinding by other human RecQ proteins has not
been reported yet; however, examination of individual RecQ
homolog might reveal diﬀerential preference for non-B DNA
structures [105].
Identiﬁcation and characterization of triplex unwinding
helicases have signiﬁed the critical importance of triplex
resolution for genomic stability. This is highlighted by the
fact that mutations in WRN, BLM, FANCJ lead to genomic
instability and certain cancer in humans [157], whereas
homozygous DHX9 knockout mice are embryonic lethal
[158]. Cellular DNA metabolic processes involve transient
formation of ssDNA which can possibly interact with other
strands to form secondary and tertiary structures [159].
If triplexes are not resolved, they can potentially interfere
with processes such as DNA replication, recombination, and
repair [129]. Further investigations to uncover the roles of
helicases in resolving triplex DNA structures are necessary
for understanding the cellular mechanism(s) for genome
stability maintenance.
3.3. G4 DNA
3.3.1. G4 DNA Structures and Their Occurrence in Genomes.
G-quadruplexes form in vitro in guanine-rich sequences that
contain four tracts of at least three guanines separated by
other bases and are stabilized by G-quartets [160]. The G-
quartets arise from the association of four guanines into a
cyclic Hoogsten hydrogen-bonding arrangement in which
each guanine base makes two hydrogen bonds with its
neighbor using diﬀerent hydrogen-bonding positions to the
canonical Watson-Crick base pairing. The planar G-quartets
stackontopofeachother,givingrisetofour-strandedhelical
structures(Figure 2(d)).Thesestructures,calledG-tetraplex,
G-quadruplex, or G4 DNA, may involve intramolecular orJournal of Nucleic Acids 7
intermolecular interactions, and the phosphodiester back-
bones of the four participating strands may be in parallel
or antiparallel orientation [161] (Figures 2(e) and 2(f)). The
formation of G4 structures is strongly dependent on mono-
valent cations such as K+ and Na+ and, hence, physiological
buﬀer conditions favor their formation, and it has been
suggested that G4 DNA may be routinely assembled and
disassembled within cells [162].
Thehumangenomecontainsnearly376000distinctsites
with the potential to form G4 DNA [163, 164], and the evi-
denceforinvivoformationofG4DNAhasemergedinrecent
years [165]. Notably, G4 DNA has been observed by electron
microscopy from transcribed human G-rich DNA arrays in
bacteria [166] and by immunochemistry at the end of the
ciliate Oxytricha telomeres [167]. The G-rich chromosomal
domains predicted to form G4 DNA include four classes
of repetitive regions: telomeres, rDNA, immunoglobulin
heavy chain switch region, and G-rich minisatellites [168].
Replication, recombination, transcription, and telomeric
DNAelongationinvolvestepsinwhichtwostrandsofduplex
DNA can be unwound transiently, providing an opportunity
for the G-rich strand to form quadruplex structures during
these DNA metabolic events [165]. Formation of G4 DNA
modulates key cellular processes such as immunoglobulin
gene rearrangement, promoter activation, and telomere
maintenance [169].
3.3.2.G4DNAandGenomicInstability. Adirectlinkbetween
potential G4-forming sequences and genomic instability
has been provided by genetic studies in model organisms.
DOG-1 (deletions of guanine-rich DNA), an ortholog of
mammalian FANCJ helicase, is essential for the stability of
G-tracts in the genome of C. elegans [170, 171]. Worms
defective in DOG-1 accumulate deletions in regions of
the genome containing long G-tracts [171] whereas the
introduction of a G-quadruplex-forming DNA sequence
into C. elegans is highly mutagenic and is removed from
genomes lacking DOG-1 [170]. FANCJ is one of the 13
known genes which lead to Fanconi anemia, and cells
from patients lacking functional FANCJ accumulate large
genomic DNA deletions that map to potential G4-forming
sequences [172]. Moreover, FANCJ preferentially unwinds G
quadruplexes over other DNA substrates in vitro suggesting
that the FANCJ helicase, like DOG-1, functions in resolv-
ing potential replication impediments caused by DNA G-
quadruplexes[156].TheRTEL(regulatoroftelomerelength)
helicase, another DOG-1 homolog, has a very clear role
at telomeres in mice, and RTEL-deﬁcient embryonic stem
cells exhibit chromosome-end fusions lacking detectable
telomere signals [173]. It is suggested that G-quadruplexes
impose a structural barrier to DNA replication and various
nucleic acid processing enzymes and are a potential source
of genetic instability if not resolved. Identiﬁcation of several
DNA helicases that eﬃciently unwind and disrupt G4 DNA
indicates that eukaryotic cells possess the mechanism for
resolution of G4 DNA structures.
3.3.3. Resolution of G4 DNA by RecQ Helicases. RecQ family
members are prominent in that they preferentially unwind
tetraplex DNA [37]. The E. coli RecQ [174], yeast SGS1
[175], and human WRN [176]a n dB L M[ 177] proteins have
been demonstrated to melt synthetic G4 DNA constructs.
Both SGS1 and BLM unwind G4 DNA with at least 15-fold
preference relative to duplex substrates [175, 178, 179]a n d
HJ structures [178]. This substrate preference correlates with
the binding aﬃnity and maps to the conserved RQC region
of the RecQ proteins [41]. The G4 DNA unwinding activity
is proposed to contribute in the maintenance of two G-rich
genomic domains, rDNA and telomeres. SGS1 is required
for recombination-mediated lengthening of telomeres in
telomerase-deﬁcient S. cerevisiae [180–182]. Furthermore,
SGS1-deﬁcient cells are characterized by nucleolar fragmen-
tation and production of rDNA circles suggesting a role of
SGS1 in rDNA metabolism [183, 184]. A possible role of
WRN in rDNA metabolism is indicated by the fact that a
signiﬁcant fraction of WRN is nucleolar [185]. Notably, cells
from Werner syndrome patients show premature senescence
and accelerated rates of telomere shortening [186]. WRN
helicase was shown to be necessary for preventing dramatic
telomere loss during lagging-strand replication of the G-rich
strand and the consequent accumulation of chromosome
aberrations such as chromosome fusions [187]. Consistent
with a role in telomere maintenance, the WRN helicase is
localized to telomeres, possibly via its interaction with TRF2
which also binds BLM [188, 189].
By resolving the tetraplex and other non-B DNA
structures, RecQ proteins might clear the way for DNA
polymerase during replication or repair synthesis. Insupport
of this hypothesis, Kamath-Loeb et al. demonstrated that
physicalassociationofDNApolymeraseδ withWRNenables
unwinding of tetraplex (and hairpin) structures by the
helicaseandallowspolymerasetopassthroughtheroadblock
[190, 191]. WRN was also shown to physically interact with
p50 subunit of human pol δ which constitutes the active
dimeric core of the enzyme with p125 subunit [192]. Thus
a possible function of WRN (and presumably other RecQ
proteins) might be the recruitment of this polymerase to the
complexsecondarystructuresandrestorationofstalledDNA
synthesis. Indeed, stimulation of DNA polymerase activity of
pol δ by BLM and stimulation of BLM helicase activity by
pol δ have been demonstrated [193]. Cellular phenotypes
of genetic mutants and the demonstration of robust G4-
unwinding activity in vitro support the notion that failure to
unwind G4 DNA contributes in part to the genetic instability
observed in Bloom and Werner syndrome cells.
Yet, RecQ proteins are not the only helicases known to
resolve G4 structures. Besides FANCJ and its orthologs, Pif1
(petite integration frequency 1), a 5 -3  helicase, processes
G4-forming sequences in vivo and in vitro [194]. Human
Pif1 helicase has been shown to bind and unwind G-
quadruplex DNA [195]. In yeast, the involvement of Pif1 in
telomere stability has been well established [196], and the
association of hPif1 with telomeres and telomerase [197]
indicates that hPif1 is a telomere G4 DNA-binding protein.
Using genome-wide chromatin immunoprecipitation and
Pif1-deﬁcient cells, Zakian group has recently demonstrated
that G4 motifs are a signiﬁcant subset of the in vivo binding
sites of the S. cerevisiae Pif1, and DNA replication through8 Journal of Nucleic Acids
G4 motifs is promoted by the S. cerevisiae Pif1 DNA helicase
[198]. The G4 DNA resolving activity of mammalian Pif1
is of questionable signiﬁcance as such since the Pif1-null
micearenormal[199],acontrastingconditionwithWRNor
BLM-deﬁcient cells where genomic instability can be readily
detected. It is conceivable that Pif1 activity is normally
unnecessary,withsuﬃcientG4resolvaseactivityprovidedby
other helicases (e.g., WRN, BLM, and FANCJ). It is possible
that a requirement for Pif1 in mammalian cells would be
obvious when one or more of these other G4 resolvase
systems are compromised.
G4 resolution is, nevertheless, not a common character-
istic of all RecQ helicases. Recently, it was demonstrated that
RECQ1 does not unwind G-quadruplex substrates [105].
The inability to resolve this particular form of alternate DNA
structuredistinguishesRECQ1fromWRN,BLM,SGS1,orE.
coli RecQ helicases which proﬁciently unwind a variety of G-
quadruplex DNA substrates [45]. Furthermore, the telomere
lengths of RECQ1 wild-type, knockout, or heterozygous
mouse cells show no signiﬁcant diﬀerence suggesting mini-
mum to no role of RECQ1 in telomere maintenance [200].
However, RECQ1 was puriﬁed with human telomeric chro-
matin speciﬁcally in cells that use a recombination mediated
pathway known as Alternative Lengthening of Telomeres
(ALTs) for telomere maintenance [201]. It is possible that
RECQ1 plays indirect role in telomere metabolism via its
interacting partners. Supporting this notion, recent evidence
suggests that SGS1 regulates processing of telomeres by the
5 -3  exonuclease, EXO1 [202]. Interestingly, RECQ1 and
EXO1 exhibit physical and functional interaction in human
cells [203]; however, it remains to be tested whether they col-
laborateinacomplexforaccurateprocessingofchromosome
ends.
Regardless, it has been demonstrated through various
studies that certain RecQ helicases are crucial for the meta-
bolism of G4 DNA structures at speciﬁc genome locations
such as telomeres and rDNA. Mutant phenotypes in yeast
and humans aﬃrm vital importance of this function of RecQ
helicases in genome maintenance.
4. Concluding Remarks andOutlook
Proﬁciency of RecQ helicases in unwinding alternate DNA
structures has implicated them as roadblock removers for
replication fork progression since the DNA sequences that
can form unusual, non-B-form structures have been shown
to block polymerases in vitro [21]. It has been proposed
that at least one function of the RecQ DNA helicases is
to prevent aberrant deleterious recombinogenic pathways
when replication is perturbed by DNA damage, alternate
DNA structure, or impaired DNA synthesis [204]. The
processing of aberrant DNA structures by RecQ helicases is
likely to counter their potential toxicity incurred by recom-
binogenic pathways [205]( Figure 3). The ability of helicases
to unwind non-B DNA structures would be expected to
increase access to repair and replication proteins. The RecQ
helicasesworkinclosecoordinationwithotherproteins(e.g.,
topoisomerases) to resolve various secondary structures.
Structural barrier to
fork progression
Resolution by
RecQ helicases
Figure 3: Proposed function of secondary structure resolution
by RecQ helicases. Alternate DNA structures (indicated by red
symbol) act as natural barrier to replication fork progression
and can lead to fork stalling, collapse and ensue recombinogenic
processing. Resolution by RecQ helicases is proposed to serve as
roadblock remover for smooth progression of replication fork to
avoid mutagenesis and/or genome rearrangements.
Associations of RecQ helicases with proteins critical for
v a r i o u ss t e p so fD N Ar e p l i c a t i o na n dr e p a i r[ 37]s u g g e s t
that RecQ helicases might cooperate with them to ensure
faithful progression of replication forks through natural
impediments by non-B DNA structures. It is likely that
there is competition between the proteins which promote
non-B secondary structure formation and RecQ helicases
in vivo. Future studies will uncover how the activities of
RecQ-helicases are controlled/regulated (via protein-protein
interactions, posttranslational modiﬁcations, etc.) for main-
taining genomic stability in general and preventing non-B
DNA structure-induced instability in particular.
As noted above, RecQ proteins exhibit subtle but note-
worthy diﬀerences among themselves with respect to their
ability to unwind or preference for certain alternate DNA
structures. Evidently, current data implies that individual
human RecQ homologs are uniquely required to unwind
speciﬁc DNA structures in vivo. Further investigation is
essential to elucidate cellular environment, genomic con-
texts, and/or protein factors that license a speciﬁc RecQ
protein to metabolize speciﬁc DNA structures in vivo.I t
is clear that non-B structures both perform physiological
roles and potentiate genomic instability. Analyses of the
mutation spectrum and genomic rearrangements in RecQ-
deﬁcient cells will illustrate signiﬁcance of RecQ helicases in
underlying mutational mechanisms associated with non-B
DNA structures [206].
Anopportunisticaspectoftheuniquenatureofnaturally
occurring non-B DNA conformations is to use them as
potential target for cancer therapy since these sequence-
speciﬁc structures are proposed to aﬀect gene expression and
telomere activation, respectively [207, 208]. Gene expression
of oncogenes could be selectively inhibited by using chem-
icals (drugs) or small molecules targeted to speciﬁc non-
B DNA conformation present in their regulatory regions
[129, 209]; stabilizing the secondary structures would be
predicted to prevent access of nucleic acid binding proteins
and interfere with critical cellular processes. Considering the
demonstrated roles of RecQ helicases in resolving such non-
B DNA structures, speciﬁc inhibition of RecQ and other
non-B resolving helicases via small molecules [210], DNA-
binding drugs or gene silencing might be a promising strat-
egy to explore for anticancer therapy [207]. Development of
new methodologies to investigate speciﬁc functions of non-BJournal of Nucleic Acids 9
DNA structures and identiﬁcation of novel structure-speciﬁc
DNA helicases involved in resolution of such secondary
structureswillcertainlyexpandthearrayofmoleculartargets
availablefordrugdevelopmentandtherapeuticintervention.
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